Behance
—
Shane Schaffer, co-founder, Chairman, and CEO of Cingulate Therapeutics based in Kansas City, Kansas, leads a Phase 3 clinical-stage biopharmaceutical company known for its pioneering work in ADHD and expanding into anxiety disorders and insomnia. With a 25-year background in the pharmaceutical industry, his expertise spans drug development and commercialization, earning him recognition for his innovative approaches to product launches and brand management.